News

The Michigan Cancer Consortium (MCC) has selected two Barbara Ann Karmanos Cancer Institute researchers and Wayne State University School of Medicine Department of Oncology faculty members as at-large board members for 2026-2027. Population Studies Research Program members, Theresa Hastert, Ph.D., associate professor, and Hayley Thompson, Ph.D., associate center director of Community Outreach and Education at Karmanos and professor, will serve on the board of the statewide partnership of public and priv...

Abstracts are now being accepted for the Science of Community Outreach and Engagement Conference (SoCOE), which will be held May 6-8 at the Cambria Hotel in downtown Detroit. The conference is held annually by the SoCOE Alliance, a group of deputy and associate directors and distinguished cancer researchers at National Cancer Institute-designated and emerging cancer centers across the nation. The group was established to advance co-learning and collaboration toward community-engaged approaches to scienc...

Karmanos Cancer Hospital, part of the Barbara Ann Karmanos Cancer Institute , has been named one of America’s Best Hospitals for Cancer Care in 2026 by the Women’s Choice Award ® , America’s trusted referral source for the best in health care. This recognition places Karmanos among the top-performing hospitals nationwide, ranking it in the top 2% of over 4,600 U.S. hospitals that offer cancer care services. This is the 13 th consecutive year Karmanos has been recognized by the Women’s Choice Award®...

Your genes play a meaningful role in your health—shaping everything from your physical features to your risk for certain medical conditions, including cancer. While most cancers are not inherited, about 5% to 10% of cases can be linked to hereditary factors. If cancer has touched your family, learning more about your genetic risk can be an important step toward protecting your future. There is a lot of information online about genetics and cancer, and trying to sort through it by yourself can feel overw...

WDIV Catching breast cancer early, before it spreads, gives patients better treatment options and outcomes. Hadeel Assad, M.D. , medical oncologist, co-leader of the  Breast Cancer Multidisciplinary Team  (MDT), member of the  Phase I Clinical Trials MDT , joined Local 4’s Live in the D to talk about breast cancer screening, advancements in treating breast cancer, clinical trials and why women should get a second opinion when they are diagnosed with breast cancer. Watch the interview here .

Leslie Cameron Devereaux’s memory lives on at the Barbara Ann Karmanos Cancer Institute in her father’s name, Richard C. Devereaux. Upon her death, she gave a lasting gift that will allow Karmanos cancer researchers to move the needle forward in the treatment of lung cancer. The Richard C. Devereaux Foundation donation has made possible the establishment of the Richard C. Devereaux Foundation Endowed Chair for Lung Cancer Research at Karmanos Cancer Institute, which was awarded to Hirva Mamdani, M.D. , ...

The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc , medical oncologist, to the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT). Dr. Choucair joins the team after completing his hematology and oncology clinical fellowship at Karmanos, where he served as chief fellow and worked closely with Karmanos oncologists and scientific researchers. He began seeing patients in July 2025 at Karmanos Cancer Center in Detroit and Karmanos Cancer Institute – Dearbo...

WSGW Pancreatic cancer is the third deadliest cancer in the U.S. There is no recommended screening for people at average risk, so it is important to understand the modifiable and non-modifiable factors, including conditions, genetic mutations and syndromes, that can lead to a higher risk of developing this disease. Wasif Saif, M.D., MBBS , medical oncologist and co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  at Karmanos, joined the Art Lewis Show to disc...

Patient Power A recent study presented at the American Society of Hematology (ASH) Annual Meeting compared treatment for CLL between academic centers and community cancer centers. Jay Yang, M.D. , hematologist, medical oncologist and leader of the  Hematology Oncology Multidisciplinary Team at Karmanos, commented on the study results, which showed that patients who received care at an academic center lived slightly longer. Dr. Yang also provided insight into a possible reason for the difference in ...

(From left to right, Stuart E. Raider, MJSF president; Jeffrey Zonder, M.D.; and Don Rudick, former MJSF director) The Barbara Ann Karmanos Cancer Institute holds a special place in the hearts of those who have been touched by its life-saving mission. Thanks to the community's philanthropic support, Karmanos continues to pursue groundbreaking research that fulfills our promise to provide every patient with the best chance. At this year’s 34 th Annual Hank Greenberg Memorial Golf, Tennis and Pickleball I...